Debt-to-equity of Verona Pharma plc from 30 Sep 2021 to 30 Jun 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Verona Pharma plc quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 30 Jun 2025.
  • Verona Pharma plc Debt-to-equity for the quarter ending 30 Jun 2025 was 133%, a 187% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Verona Pharma plc Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2025 133% +87% +187% 30 Jun 2025
Q1 2025 149% +131% +720% 31 Mar 2025
Q4 2024 117% +101% +653% 31 Dec 2024
Q3 2024 83% +70% +540% 30 Sep 2024
Q2 2024 46% +32% +227% 30 Jun 2024
Q1 2024 18% -0.17% -0.93% 31 Mar 2024
Q4 2023 16% -6.2% -29% 31 Dec 2023
Q3 2023 13% -13% -51% 30 Sep 2023
Q2 2023 14% -15% -51% 30 Jun 2023
Q1 2023 18% -12% -39% 31 Mar 2023
Q4 2022 22% -2.2% -9% 31 Dec 2022
Q3 2022 26% +6.4% +32% 30 Sep 2022
Q2 2022 29% 30 Jun 2022
Q1 2022 30% 31 Mar 2022
Q4 2021 24% 31 Dec 2021
Q3 2021 20% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.